A comprehensive view of european medicines agency (ema). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

CHMP recommends marketing authorization in EU for Pfizer and BioNTech's Omicron JN.1-adapted monovalent COVID-19 vaccine for individuals six months of age and older

GSK Group (GlaxoSmithKline) Advances Oncology and Blood Cancer Therapies with EMA Validation and Japan MHLW Approval, Champions Sustainability and Advocates for Preventative Vaccinations

European Medicines Agency validates Bristol Myers' application for Opdivo nivolumab plus Yervoy ipilimumab for the first-line treatment of adult patients with microsatellite instability–high or mismatch repair deficient metastatic colorectal cancer

Amgen submits marketing authorization application to the European Medicines Agency for teprotumumab treatment for moderate to severe thyroid eye disease in adults; if approved, teprotumumab would be the first approved medicine for TED in the EU

CHMP adopts positive opinion recommending approval of Bristol Myers Squibb’s Opdivo nivolumab in combination with Cisplatin and Gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count